Browse > Article

EFFECT OF ZOLEDRONATE TO BONE HEALING PROCESS AFTER ILIAC BONE GRAFT INTO MAXILLARY SINUS IN RABBIT  

Song, Jun-Ho (Department of Oral and Maxillofacial Surgery, Pusan Paik hospital,, Inje University)
Lee, Soo-Woon (Department of Oral and Maxillofacial Surgery, Pusan Paik hospital,, Inje University)
Park, Sang-Jun (Department of Oral and Maxillofacial Surgery, Pusan Paik hospital,, Inje University)
Publication Information
Journal of the Korean Association of Oral and Maxillofacial Surgeons / v.35, no.3, 2009 , pp. 158-163 More about this Journal
Abstract
Objective : Recently, we are interested in bisphosphonate related osteonecrosis of the jaw (BRONJ). Most of patients with osteonecrosis have taken medicine bisphosphonate for a long time. But the mechanism of osteonecrosis in BRONJ was not clarified yet. The aim of this study is to evaluate the difference of bone healing effect after bone graft from ilium to maxillary sinus in rabbits between zoledronate-treated and zoledronate-not treated groups. Method : The subjects was divided into two groups. The experimental group was 9 rabbits, treated with intraperitoneal administration of zoledronate(0.06mg/kg) once per week for 3 weeks. In control group, same procedure was applied but administerd saline instead of zoledronate. After 4 weeks, surgical operation under local anesthesia (ketamine 3.0cc, xylazine 1.0cc) was done. At postoperative 1, 2, 4, 8 weeks later, each rabbits were sacrificed and removed the bone grafted area. Gross, radiologic and histopathologic exminations of bone grafted area were performed. Result : There were no conspicuous differences of radiological findings between experimental and control groups in any experimental weeks. In experimental group, new bone formation appeared earlier than control group at 1 week after operation, and maturation of bony tissue were more conspicuous at 2 and 4 weeks after operation, compared with control group. In 8 weeks after operation, similar microscopic findings were noted in both groups. Conclusion : In the bisphosphonate-treated rabbits, new bone formation in the bone grafted area appeared earlier and bony maturation was more concpicuous, even though there were no significant differences of gross and radiological findings. These findings suggest that bisphosphonate might be promotive effect in the healing process in early stage after administration.
Keywords
Bisphosphonate; Zoledronate; Bone graft; Bone healing;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Schmidli RS, Wilson I. Aminopropylidene bisphosphonate(APD) in mild primary hyperparathyroidism : effect on clinical status. Clin Endocrinol 1990;32:293-300   DOI   PUBMED
2 Hughes DW. Inhibition of osteoclast-like cell formation by bisphosphonatein long-term cultures of human bone marrow. J ClinInvest 1989; 83:1930-5   DOI
3 Yu X, Scholler J. Pretreatment of an osteoblastic like cell linewith bisphosphonates inhibits its PTH-stimulated induction of osteoclasticbone resorption. J Bone Miner Res [Suppl 1] 1994;9:S232(abstract)
4 Nakagawa N, Yasuda H. Basic fibroblast growth factor inducesosteoclast formation by reciprocally regulating the production ofosteoclast differentiation factor and osteoclastogenesis inhibitoryfactor in mouse osteoblastic cells. Biochem Biophys ResCommun 1999;265:158-63   DOI   ScienceOn
5 Brunsvold MA. Effect of a bisphosphonate on experimental periodontitisin monkeys. J Periodontol 1992;63:825-30   DOI   PUBMED
6 American Association of Oral and Maxillofacial surgeon.Position Paper on Bisphosphonate-Related Osteonecrosis of the jaw-2009 Update 4 page
7 Adami S, Bolzicco GP. The use dichloromethylene bisphosphonateand aminobutane bisphosphoate in hypercalcemia of malignancy. Bone Miner 1987;2:395-404
8 Zhang FL, Casey PJ. Protein prenylation : molecular mechanismand functional sequences. Annu Rev Biochem 1996;65:241-69   DOI   ScienceOn
9 Burcu OC, Gonca CK. Effect of risedronate on alveolar bone loss and angiogenesis: a stereologic study in rat. J. Periodontol 2008;79:1955-9   DOI   ScienceOn
10 A. Alper. Experimental evaluation of the effects of zoledronicacid on regenerate bone formation and osteoporosis in mandibularDO, J. oral and maxillofacial surgery 2006;64:1232-6   DOI   ScienceOn
11 Shoji K, Horiuch H. Inhibitory effects of a bisphosphonate(residronate) on experimental periodontitis in rats. J periodontolRes 1995;30:277-84   DOI   ScienceOn
12 Adachi H, Igarashi K. Effects of topical administration of a bisphosphonate(risedronate) on orthodontic tooth movements in rat. J Dent Res 1994;73:1478-84   DOI   ScienceOn
13 Regina Landesberg. Inhibition of oral mucosa cell wound healingby bisphosphonates, J. oral and maxillofacial surgery 2008;66:839-7   DOI   ScienceOn
14 Passeri M, Baroni MC. Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1, 1-bisphosphonate (AHBuBP) inthe therapy of postmenopausal osteoporosis. Bone Miner 1991;15:237-48   DOI   ScienceOn
15 Audran M, Clochon P. Treatment of Paget's disease of bone with(4-chlorophenyl) thiomethylene bisphosphonate. Clin Rheumatol1989;8:71-9   DOI   ScienceOn
16 Grynpas MD, Acito A, Dimitriu M, Mertz BP, Very JM.Changes in bone mineralization, architecture and mechanicalproperties due to long-term (1 year) administration ofpamidronate (APD) to adult dogs. Osteoporos 1992; Int 2:74-81   DOI   ScienceOn
17 Schenk R, Merz WA. Effect of EHDP and Cl2MDP on the calcificationand resorption of cartilage and bone in the tibial epiphysisand metaphysics of rat. Calcif Tissue Res 1973;11:196-214   DOI   ScienceOn
18 Tenenbaum HC, Torontail M. Effect of Bisphosphonates and Inorganic Pyrophosphate on osteogenesis in vitro. Bone 1992;13:249-55   DOI   ScienceOn
19 L.E. Bilston. Zoledronic acid improves the mechanical propertiesof normal and healing bone. Clin Biomech 2002;17:716   DOI   ScienceOn
20 Luckman SP, Hughes DE, Coxon FP. Nitrogen-containing bisphosphonatesinhibit the mevalonate pathway and prevent posttranslationalprenylation of GTP-bonding proteins, including Ras.J Bone Miner Res 1998;13:581-9   DOI   ScienceOn
21 Sahni M, Grunther HL. Bisphosphonates act on Rat bone resorptionthrough the medication of osteoblast. J Clin Invest 1993;91:2004-11   DOI   ScienceOn
22 Hughes DE, Wright KR. Bisphosphonate promote apoptosis inmurine osteoclasts in vitro and in vivo. J Bone Miner Res 1995;10:1478-87   DOI   ScienceOn
23 Alakangas A, Selander K, Mulari M, Halleen J. Aledronate disturbsvesicular trafficking in osteoclasts. Calcif Tissue Int 2002;70:40-7   DOI   ScienceOn
24 Fleisch H, Russel RGG, Bisaz S et al. The influence of pyrophosphate analogues (diphosphonates) on the precipitation and dissolution of calcium phosphate in vitro and in vivo. Calcif TissueRes, Supple 1968;2:10-10A   DOI
25 Sahni M, Guenther HL, Fleisch. Bisphosphonates act on rat boneresorption though the medication of osteoblasts. J Clin Inves1993;91:2004-11   DOI   ScienceOn
26 O'uchi N, Nishikawa H. Inhibitory effects of YM175, a bisphosphonate,on the progression of experimental periodontitis in beagle dogs. J Periodontal Res 1998;33:196-204   DOI   ScienceOn
27 Vitte C. Fleisch. Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption. Endocrinology1996;137:2324-33   DOI   ScienceOn
28 Igarashi K, Mitani H. Anchorage and retensive effects of a bisphosphonate(AHBuBP) on tooth movements in rat. Am J OrthodDentofac Orthop 1994;106:279-89   DOI   ScienceOn
29 Cocchini MG, Fleisch H. Bisphosphonate in vitro specifically inhibit,among the hematopoietic series, the development of themouse mononuclear phagocyte lineage. J Bone Miner Res 1990;5:1019-27   DOI   ScienceOn